Double Medical Technology Inc. (002901.SZ): Shareholder holds equity in the subsidiary of a company.

On March 24, Glonghui reported that Double Medical Technology Inc. (002901.SZ) announced that Xiamen Junlaixin Investment Co., Ltd. (referred to as "Junlaixin") is a shareholder of the company's holding subsidiary, Shide (Xiamen) Medical Equipment Co., Ltd. (referred to as "Shide"), which holds 51% of the shares. The company's major shareholder, Guangxi Dabosmart Investment Co., Ltd. (referred to as "Dabosmart"), plans to sign an Equity Transfer Agreement with Junlaixin shareholders Liao Baoyong and Wu Qiaoli, whereby Dabosmart intends to use its own funds of 47,270,437.97 yuan to acquire all the shares held by Junlaixin shareholders Liao Baoyong and Wu Qiaoli. This equity transfer.

Gelonghui FinanceMar 24 17:07

Express News | Double Medical Technology Inc.: The major shareholder Double Shangtong plans to acquire all the equity of Junlaixin for 47.27 million yuan, indirectly increasing the shareholding of Shi Aide Medical to 23.5%.

BreakingsMar 24 16:58

Express News | A total of 955 A-share listed companies have released their 2024 annual performance forecasts, with Jiangsu Zhengdan Chemical Industry predicting a year-on-year net profit increase of up to 13,064%.

BreakingsJan 19 20:01

The market reacted with a limit-up! The annual report season for A-shares has begun, and some listed companies are expected to have year-on-year increases of more than eight times.

① The annual report trend for A-shares is gradually unfolding. After Zhejiang Dibay Electric announced a performance forecast increase last Thursday, it achieved three consecutive limit-ups on Tuesday; after Whirlpool announced a performance forecast increase last Friday, it achieved two consecutive limit-ups on Tuesday; on the day after announcing its performance forecast increase, Xizi Clean Energy Equipment Manufacturing reached a limit-up. ② A review of the list of A-share listed companies expected to have the highest net income growth of over 100% year-on-year in 2024 and the reasons for the changes in performance (attached table).

cls.cnJan 11 16:37

Dabo Healthcare: 2024 Annual Performance Forecast

SZSIJan 11 00:00 · Announcements

Express News | Double Medical Technology Inc.: The net income is expected to increase by 493.50%–561.33% year-on-year in 2024.

BreakingsJan 10 18:13